7:00a | Educational Conference | Dana 9
Journal Club: A discussion of TNT in rectal cancer. We will discuss the two articles below, attached to this post.
- Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
- Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy A Secondary Analysis of the OPRA Randomized Clinical Trial